RxDoctor Payments Data

Omer Ibrahim

Dermatology · Chicago, ILNPI 1871869438

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $210,400 of the $312,688 with a category attached, or 67.3%. Lilly USA, LLC accounts for 69.5% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2023 at $117,476 and has fallen 90.8% since, to $10,837 in 2025. Among dermatology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$312,688in general payments, 2019–2025

Across 569 payments — averaging $549.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$217K
  • AbbVie$79K
  • Galderma Laboratories, L.p.$8K
  • Solta Medical, A Division Of Bausch Health US, LLC$4K
  • Merz North America, Inc.$748
  • Novartis$433
  • plus $3K from 30 others
$70in research payments, 2019–2025

Across 1 payment — averaging $70.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$70

What the payments were for

  • Consulting fees$77,62125%
  • Speaking & faculty fees$210,40067%
  • Travel & lodging$12,7834%
  • Food & beverage$11,5414%
  • Education$3440%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$312,688 in reported general payments places this provider in the 95th percentile of 606 dermatology providers in Illinois.

See all dermatology providers in Illinois

Medicare billing

Part B allowed, 2024
$5,393
Medicare patients
24
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dutasteride43$1,410
Spironolactone33$755
Minoxidil69$734
Prednisone17$23

Paid to pharmacies, not to this prescriber.

Other dermatology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →